You are here: Industry Insights > Wuxi Biologics

News List

WuXi Biologics to build new CDMO plant biospectrumasia
May 18, 2018
WuXi Biologics is planning to build an integrated biologics development, clinical and commercial manufacturing centre in the city of Shijiazhuang, capital of Hebei province in northern China.
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland en-cphi.cn
May 07, 2018
An Taoiseach Leo Varadkar is to invest €325 million and create 400 new jobs over five years in a new biologics drug substance manufacturing facility on the Industrial Development Authority's (IDA) greenfield site in Mullagharlin, Dundalk, Co. Louth.
China's WuXi Biologics to build biologics plant in Ireland that will employ 400 fiercepharma
May 04, 2018
Just months after completing China’s largest single-use bioreactor manufacturing facility, WuXi Biologics is ready to take its technology to Europe with another large biologics facility that will employ 400 workers.
WuXi Biologics to build biomanufacturing facility in Ireland biospectrumasia
May 03, 2018
This facility will create approximately 700 jobs during its construction and over 400 highly skilled jobs after establishment over 5 years.
WuXi Biologics to install largest CSR disposable Bioreactor biospectrumasia
March 22, 2018
The 4,000L CSR is the largest single-use bioreactor size available in the industry and potentially largest-ever design in conventional disposable bioreactors
WuXi Biologics to Install Industry's Largest Single-Use Bioreactor from ABEC at its New Commercial M prnasia
March 22, 2018
WuXi Biologics today announced that it has selected 4,000 liter (L) Custom Single Run (CSR®) disposable bioreactors from ABEC for its new commercial manufacturing facility (MFG4) in Wuxi city, Jiangsu, China.
WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618 prnasia
March 20, 2018
WuXi Biyman) Inc. offering end-to-end solutions for biologics discovery, development aologics (Cand manufacturing, announced its audited annual results for the year ended December 31, 2017 today.
WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership prnasia
March 12, 2018
WuXi Biologics (2269.HK) and Adagene Inc.,today announced a strategic collaboration agreement.
WuXi Biologics gets recognition at Biopharma Industry Awards biospectrumasia
March 08, 2018
The BioPharma Industry Awards Ceremony was held at 2018 Phar-East Asia Pharma & Biotech Festival on 1st March, 2018.
WuXi Biologics Congratulates TaiMed on FDA Approval for Trogarzo prnasia
March 08, 2018
Wuxi Biopharmaceutical congratulates its partner Taimai Biological Products Co., Ltd. for obtaining FDA approval of Trogarzo (ibalizumab)

Previous page 1 2 3 4 5 6 7 8 9 10 Next page